Goldman Sachs’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.81M | Buy |
|
|||||
|
2025
Q1 | $1.94M | Sell |
|
|||||
|
2024
Q4 | $4.09M | Sell |
|
|||||
|
2024
Q3 | $9.88M | Buy |
|
|||||
|
2024
Q2 | $7.7M | Buy |
|
|||||
|
2024
Q1 | $14.8M | Buy |
|
|||||
|
2023
Q4 | $2.21M | Buy |
|
|||||
|
2023
Q3 | $1.05M | Sell |
|
|||||
|
2023
Q2 | $5.16M | Sell |
|
|||||
|
2023
Q1 | $7.57M | Buy |
|
|||||
|
2022
Q4 | $8.17M | Sell |
|
|||||
|
2022
Q3 | $23.3M | Sell |
|
|||||
|
2022
Q2 | $26.9M | Buy |
|
|||||
|
2022
Q1 | $8.78M | Sell |
|
|||||
|
2021
Q4 | $23.8M | Sell |
|
|||||
|
2021
Q3 | $33.8M | Sell |
|
|||||
|
2021
Q2 | $51.5M | Sell |
|
|||||
|
2021
Q1 | $67.6M | Buy |
|
|||||
|
2020
Q4 | $70.5M | Sell |
|
|||||
|
2020
Q3 | $52.3M | Buy |
|
|||||
|
2020
Q2 | $35.8M | Buy |
|
|||||
|
2020
Q1 | $16.5M | Buy |
|
|||||
|
2019
Q4 | $13.2M | Buy |
|
|||||
|
2019
Q3 | $7.09M | Buy |
|
|||||
|
2019
Q2 | $9.02M | Buy |
|
|||||
|
2019
Q1 | $6.66M | Buy |
|
|||||
|
2018
Q4 | $4.43M | Buy |
|
|||||
|
2018
Q3 | $1.62M | Buy |
|
|||||
|
2018
Q2 | $310K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $311K | Sell |
|
|||||
|
2017
Q3 | $500K | Buy |
|
|||||
|
2017
Q2 | $362K | Sell |
|
|||||
|
2017
Q1 | $655K | Buy |
|
|||||
|
2016
Q4 | $62K | Sell |
|
|||||
|
2016
Q3 | $111K | Sell |
|
|||||
|
2016
Q2 | $61K | Sell |
|
|||||
|
2016
Q1 | $313K | Buy |
|
|||||
|
2015
Q4 | $90K | Buy |
|
|||||
|
2015
Q3 | $79K | Buy |
|
|||||
|
2015
Q2 | $79K | Sell |
|
|||||
|
2015
Q1 | $181K | Sell |
|
|||||
|
2014
Q4 | $369K | Sell |
|
|||||
|
2014
Q3 | $427K | Buy |
|
|||||
|
2014
Q2 | $428K | Buy |
|
|||||
|
2014
Q1 | $256K | Sell |
|
|||||
|
2013
Q4 | $257K | Buy |
|